4 documents found, page 1 of 1
Can We Identify Patients with High Risk of Osteoarthritis Progression Who Will ...
Arden, Nigel; Richette, Pascal; Cooper, Cyrus; Bruyère, Olivier; Abadie, Eric; Branco, Jaime; Brandi, Maria Luisa; Berenbaum, Francis; Clerc, CécileFunding: This meeting was founded by the European Society for Clinical and Economics Aspect of Osteoporosis and Osteoarthritis, a not for profit organization from Belgium.; Osteoarthritis (OA), a disease affecting different patient phenotypes, appears as an optimal candidate for personalized healthcare. The aim of the discussions of the European Society for Clinical and Economic Aspects of Osteoporosis and Oste...
Can We Identify Patients with High Risk of Osteoarthritis Progression Who Will ...
Bruyère, Olivier; Cooper, Cyrus; Arden, Nigel; Branco, Jaime; Brandi, Maria Luisa; Herrero-Beaumont, Gabriel; Berenbaum, Francis; Dennison, ElainePublisher Copyright: © 2015, The Author(s).; Osteoarthritis is a syndrome affecting a variety of patient profiles. A European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis and the European Union Geriatric Medicine Society working meeting explored the possibility of identifying different patient profiles in osteoarthritis. The risk factors for the development of osteoarthritis incl...
A reference case for economic evaluations in osteoarthritis
Hiligsmann, Mickaël; Cooper, Cyrus; Guillemin, Francis; Hochberg, Marc C.; Tugwell, Peter; Arden, Nigel; Berenbaum, Francis; Boers, MaartenPublisher Copyright: © 2014 The Authors.; Background: General recommendations for a reference case for economic studies in rheumatic diseases were published in 2002 in an initiative to improve the comparability of cost-effectiveness studies in the field. Since then, economic evaluations in osteoarthritis (OA) continue to show considerable heterogeneity in methodological approach. Objectives: To develop a refere...
Health economics in the field of osteoarthritis
Hiligsmann, Mickaël; Cooper, Cyrus; Arden, Nigel; Boers, Maarten; Branco, Jaime; Luisa Brandi, Maria; Bruyère, Olivier; Guillemin, FrancisFunding Information: M.H. (Mickael Hiligsmann) has received research grant, lecture fees, and/or consulting fees from Amgen, Pfizer, Novartis, Servier, and SMB. C.C. has received honoraria and consulting fees from AMGEN, GSK, Alliance for Better Bone Health, MSD, Eli Lilly, Pfizer, Novartis, Servier, Medtronic, and Roche. M.-L.B. was consultant and grant recipient from Amgen, Eli Lilly, MSD, Novartis, NPS, Roch...